FDA Pursues Consumer Products With Questionable Flu Treatment Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA continues its efforts to protect consumers from the ongoing H1N1 flu outbreak, as well as from opportunistic marketers selling potentially deceptive "cures" for the virus